![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: THSD7B |
Gene summary for THSD7B |
![]() |
Gene information | Species | Human | Gene symbol | THSD7B | Gene ID | 80731 |
Gene name | thrombospondin type 1 domain containing 7B | |
Gene Alias | THSD7B | |
Cytomap | 2q22.1 | |
Gene Type | protein-coding | GO ID | GO:0006996 | UniProtAcc | E7EM75 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
80731 | THSD7B | P2T-E | Human | Esophagus | ESCC | 1.17e-07 | 2.58e-01 | 0.1177 |
80731 | THSD7B | P12T-E | Human | Esophagus | ESCC | 1.29e-35 | 8.15e-01 | 0.1122 |
80731 | THSD7B | P16T-E | Human | Esophagus | ESCC | 3.10e-02 | 9.65e-02 | 0.1153 |
80731 | THSD7B | P56T-E | Human | Esophagus | ESCC | 3.89e-06 | 5.55e-01 | 0.1613 |
80731 | THSD7B | 048752_1579-all-cells | Human | Prostate | BPH | 5.27e-07 | 1.84e-01 | 0.1008 |
80731 | THSD7B | 052095_1628-all-cells | Human | Prostate | BPH | 1.63e-32 | 6.07e-01 | 0.1032 |
80731 | THSD7B | 052097_1595-all-cells | Human | Prostate | BPH | 1.08e-16 | 3.82e-01 | 0.0972 |
80731 | THSD7B | 052099_1652-all-cells | Human | Prostate | BPH | 7.83e-27 | 5.72e-01 | 0.1038 |
Page: 1 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:003153218 | Esophagus | ESCC | actin cytoskeleton reorganization | 72/8552 | 107/18723 | 5.03e-06 | 5.31e-05 | 72 |
GO:003153210 | Prostate | BPH | actin cytoskeleton reorganization | 40/3107 | 107/18723 | 1.82e-07 | 4.04e-06 | 40 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
THSD7B | SNV | Missense_Mutation | rs372041308 | c.4681G>C | p.Val1561Leu | p.V1561L | protein_coding | tolerated(0.09) | benign(0.124) | TCGA-86-8585-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
THSD7B | SNV | Missense_Mutation | c.3463N>A | p.Leu1155Met | p.L1155M | protein_coding | tolerated(0.12) | possibly_damaging(0.796) | TCGA-86-A4JF-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Chemotherapy | unknown | PD | ||
THSD7B | SNV | Missense_Mutation | c.862C>G | p.His288Asp | p.H288D | protein_coding | tolerated(0.2) | benign(0.165) | TCGA-91-7771-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Chemotherapy | cisplatin | CR | ||
THSD7B | SNV | Missense_Mutation | rs372735350 | c.2000C>T | p.Thr667Ile | p.T667I | protein_coding | deleterious(0) | possibly_damaging(0.806) | TCGA-95-7567-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Chemotherapy | cisplatin | SD | |
THSD7B | SNV | Missense_Mutation | c.2420N>A | p.Pro807His | p.P807H | protein_coding | tolerated(0.21) | benign(0.003) | TCGA-99-8025-01 | Lung | lung adenocarcinoma | Female | >=65 | III/IV | Chemotherapy | gemzar | SD | ||
THSD7B | SNV | Missense_Mutation | c.3818G>T | p.Arg1273Leu | p.R1273L | protein_coding | deleterious(0) | probably_damaging(0.995) | TCGA-J2-A4AD-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | PD | ||
THSD7B | SNV | Missense_Mutation | novel | c.1978N>G | p.Cys660Gly | p.C660G | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-MN-A4N4-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
THSD7B | SNV | Missense_Mutation | c.891A>G | p.Ile297Met | p.I297M | protein_coding | deleterious(0.02) | probably_damaging(0.942) | TCGA-MP-A4TA-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | ||
THSD7B | SNV | Missense_Mutation | c.2006N>A | p.Pro669His | p.P669H | protein_coding | deleterious(0) | possibly_damaging(0.896) | TCGA-NJ-A4YQ-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
THSD7B | SNV | Missense_Mutation | novel | c.3526N>A | p.Leu1176Met | p.L1176M | protein_coding | deleterious(0.01) | probably_damaging(0.999) | TCGA-NJ-A4YQ-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
80731 | THSD7B | NA | ethanol | ALCOHOL | 32451486 |
Page: 1 |